Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
DNTH: Dianthus Therapeutics, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
DNTH
The Story
DNTH
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+120.6% / yr
Operating margin
-14318.0%
ROIC
-15.8%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
29.25×
Dianthus Therapeutics, Inc.
DNTH
NASDAQ
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Dianthus Therapeutics, Inc.
DNTH
NASDAQ
·
USD
·
Closed
$106.92
−5.08%
$106.92
−$5.72 (5.08%)
52W Range
92th
pctl
Volume
0.82×
avg
Mkt Cap
4.46B
USD
P/E
-972.0
TTM
Div Yield
–
ann
52W Range
92th
pctl
Volume
0.82×
avg
Market Cap
4.46B
USD
P/E Ratio
-972.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings